Literature DB >> 22076800

Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model.

Parminder J S Vig1, Jinrong Wei, Qingmei Shao, Maripar E Lopez, Rebecca Halperin, Jill Gerber.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurological disorder caused by the expansion of a polyglutamine tract in the mutant protein ataxin-1. The cerebellar Purkinje cells (PCs) are the major targets of mutant ataxin-1. The mechanism of PC death in SCA1 is not known; however, previous work indicates that downregulation of specific proteins involved in calcium homeostasis and signaling by mutant ataxin-1 is the probable cause of PC degeneration in SCA1. In this study, we explored if targeted deprivation of PC specific calcium-binding protein calbindin-D28k (CaB) exacerbates ataxin-1 mediated toxicity in SCA1 transgenic (Tg) mice. Using behavioral tests, we found that though both SCA1/+ and SCA1/+: CaB null (-/+) double mutants exhibited progressive impaired performance on the rotating rod, a simultaneous enhancement of exploratory activity, and absence of deficits in coordination, the double mutants were more severely impaired than SCA1/+ mice. With increasing age, SCA1/+ mice showed a progressive loss in the expression and localization of CaB and other PC specific calcium-binding and signaling proteins. In double mutants, these changes were more pronounced and had an earlier onset. Gene expression profiling of young mice exhibiting no behavior or biochemical deficits revealed a differential expression of many genes common to SCA1/+ and CaB-/+ lines, and unique to SCA1/+: CaB-/+ phenotype. Our study provides further evidence for a critical role of CaB in SCA1 pathogenesis, which may help identify new therapeutic targets to treat SCA1 or other cerebellar ataxias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22076800     DOI: 10.1007/s12311-011-0323-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  52 in total

1.  Calbindin-D28k in nerve cell nuclei.

Authors:  D C German; M C Ng; C L Liang; A McMahon; A M Iacopino
Journal:  Neuroscience       Date:  1997-12       Impact factor: 3.590

2.  Differential expression of FABP 3, 5, 7 in infantile and adult monkey cerebellum.

Authors:  Nadezhda B Boneva; Yoshimi Mori; Desislav B Kaplamadzhiev; Hiromu Kikuchi; Hong Zhu; Mitsuru Kikuchi; Anton B Tonchev; Tetsumori Yamashima
Journal:  Neurosci Res       Date:  2010-07-08       Impact factor: 3.304

3.  CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.

Authors:  T L Gumienny; E Brugnera; A C Tosello-Trampont; J M Kinchen; L B Haney; K Nishiwaki; S F Walk; M E Nemergut; I G Macara; R Francis; T Schedl; Y Qin; L Van Aelst; M O Hengartner; K S Ravichandran
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

4.  Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1.

Authors:  P J Vig; J D Fratkin; D Desaiah; R D Currier; S H Subramony
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 5.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

6.  Purkinje cells express Angiotensin II AT(2) receptors at different developmental stages.

Authors:  María E Arce; Susana I Sánchez; Francisco López Aguilera; Leonardo R Seguin; Alicia M Seltzer; Gladys M Ciuffo
Journal:  Neuropeptides       Date:  2010-12-10       Impact factor: 3.286

7.  Deficiency in parvalbumin, but not in calbindin D-28k upregulates mitochondrial volume and decreases smooth endoplasmic reticulum surface selectively in a peripheral, subplasmalemmal region in the soma of Purkinje cells.

Authors:  G Chen; P Racay; S Bichet; M R Celio; P Eggli; B Schwaller
Journal:  Neuroscience       Date:  2006-07-21       Impact factor: 3.590

8.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

Review 9.  Changes in Ca(2+)-binding proteins in human neurodegenerative disorders.

Authors:  C W Heizmann; K Braun
Journal:  Trends Neurosci       Date:  1992-07       Impact factor: 13.837

10.  Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.

Authors:  Robert Goold; Michael Hubank; Abigail Hunt; Janice Holton; Rajesh P Menon; Tamas Revesz; Massimo Pandolfo; Antoni Matilla-Dueñas
Journal:  Hum Mol Genet       Date:  2007-06-28       Impact factor: 6.150

View more
  14 in total

Review 1.  SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

Authors:  Harry T Orr
Journal:  Prog Neurobiol       Date:  2012-04-16       Impact factor: 11.685

Review 2.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

3.  Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model.

Authors:  Parminder J S Vig; Scoty M Hearst; Qingmei Shao; Maripar E Lopez
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 4.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

5.  Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.

Authors:  Scoty M Hearst; Qingmei Shao; Mariper Lopez; Drazen Raucher; Parminder J S Vig
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

Review 6.  Cellular and circuit mechanisms underlying spinocerebellar ataxias.

Authors:  Pratap Meera; Stefan M Pulst; Thomas S Otis
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

Review 7.  Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.

Authors:  David D Bushart; Geoffrey G Murphy; Vikram G Shakkottai
Journal:  Ann Transl Med       Date:  2016-01

8.  Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia.

Authors:  Sherry-Ann Brown; Leslie M Loew
Journal:  BMC Syst Biol       Date:  2012-06-15

9.  Identification of CHIP as a novel causative gene for autosomal recessive cerebellar ataxia.

Authors:  Yuting Shi; Junling Wang; Jia-Da Li; Haigang Ren; Wenjuan Guan; Miao He; Weiqian Yan; Ying Zhou; Zhengmao Hu; Jianguo Zhang; Jingjing Xiao; Zheng Su; Meizhi Dai; Jun Wang; Hong Jiang; Jifeng Guo; Yafang Zhou; Fufeng Zhang; Nan Li; Juan Du; Qian Xu; Yacen Hu; Qian Pan; Lu Shen; Guanghui Wang; Kun Xia; Zhuohua Zhang; Beisha Tang
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

10.  Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.

Authors:  Stephen T Hansen; Pratap Meera; Thomas S Otis; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2012-10-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.